Register to see more features including:
No result found
Focused on supporting entrepreneurs who are building potential high-growth companies in cleantech, software, biosciences and digital health.
Base Ventrues, founded by Erik Moore, is a seed-stage fund investing in technology companies. Current portfolio includes Angellist, Virool, Surfair, SocialCal, Tracks.by/Hipset, Priceonomics, MightyText, and others. Successful exits include Socialcam (acquired by Autodesk), and Appstores (acquired by InMobi).
Erik Moore is the founder and Managing Director of Base Ventures. Erik is a passionate angel investor, entrepreneur, creative thinker, and an unabashed optimist.
After a rewarding fifteen-year career in investment banking, Erik secured an early retirement from Merrill Lynch in 2011 and at that point began pursuing his passion for entrepreneurship.
Erik formed Base Ventures from a love for investing in trailblazing tech start-ups. During the past 12-years, Erik has invested in almost two dozen trailblazing start-ups.
Erik was a seed investor in Zappos.com which was sold to Amazon for $1.2b and Agencourt Biosciences which was sold to Beckman Coulter for $270mm.
Writer contributor to Segment News, USA Herald, Boston.com, Indy, Dictated and more about how individuals can succeed at selling and developing a positive company culture. Writer reviewer of independent films and documentaries that inspire the human spirit. Promoter of talent local and international via the lively arts foundation our next 2 performances are "Mystic India" a Bollywood production October 18th and then our community favorite "Nutcracker" where we work with the school district on bussing in migrant children to watch the ballet under Arts in the Schools program.
PolySkope simultaneously detects all the most common food borne pathogens that cause death and financial ruin. Using our team's skill and expertise in clinical diagnostic multiplex assay development, we have created a multiplex pathogen detection RT-PCR assay for food. Simple and easy to use, our test uses a single overnight enrichment and sample prep to detect Shiga Toxin E. coli (including O157:H7), Salmonella and Listeria. This will reduce the cost of materials, labor, reagents, disposables, space, incubatory space, equipment and expensive instruments 3-fold. It makes comprehensive testing easy and affordable. Our C.S.O. and lead inventor, Michael Centola, previously founded Crescendo Bioscience and was lead inventor of their Vectra DA assay which sold for $270 M. This financing will take our technology through AOAC and ISO validation and into first sales.
The LinkSēq™ HLA product line is redefining the way histocompatibility laboratories type patients and donors for solid organ and stem cell transplantation. LinkSēq™ is the world's fastest, simplest method of tissue typing, providing more relevant genetic data, and dramatically increasing laboratory efficiency and cost structure. The company's core technology has been applied to companion diagnostics (adverse drug effects) and other genetic diseases (e.g. celiac disease), with an expanding catalog of products.
Currently, there is no single test to detect and predict multiple types of cancer throughout the body. Instead, multiple different tests are used to find cancer in a variety of ways. The diagnostic test Lazarus is developing will make checking for cancer as simple as checking cholesterol levels and may become a common part of a regular physical, leading to earlier detection, lower treatment costs and better patient outcomes.
MedTech Reveal - Color Changing Alcohol Detection Patch
MedTeh SplitCup (Formerly AdheRx) - Color Changing Compliance Specimen Cup
Chemical detection by way of molecular imprint in the form of a Split Specimen Cup, Swab and Patch, to detect the presence of various molecules to ensure clinical trial compliance, adherence to prescription medication, resistance to substance abuse, and to verify surface cleanliness in hospitals and food service areas. These detections are molecular, instantaneous, and can be detected at the micromolar level.
Current ventures include Alexian Brother Behavioral Health Hospital, North Shore University Health Center, and Rush University Medical Center.
Xcell Biosciences is a San Francisco-based life sciences company that has developed an innovative research and diagnostics platform utilizing its technology for capturing and growing tumor cells and immune cells directly from patient blood. By rapidly growing and expanding this rare cancer cell population into miniature tumors, the company has overcome key sample size limitations significantly impacting the ability to perform genetic analysis on this population of cells. As a result, the company is able to capture the comprehensive set of genetic information for each patient’s cancer and track changes to that dataset overtime, enabling the company to create a highly scalable, first-in-class big data solution for cancer. This patient-centric company is developing the platform as a high content liquid biopsy tool for cancer research and clinical use, including screening, monitoring, and managing unpredicted changes to a patient’s disease
Roka pathogen detection assays combine the full power of Target Capture, Transcription-Mediated Amplification, and Hybridization Protection Assay to provide the most advanced food safety testing solutions available
At Twist Bioscience, our expertise is synthetic DNA. We have developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes. By synthesizing DNA on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic DNA production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. The Twist Bioscience platform has the potential to greatly accelerate the development of personalized medicine, sustainable chemical production, improved agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. For more information, please visit www.twistbioscience.com .
A division of the Maricopa Corporate College, the Center for Entrepreneurial Innovation (CEI) is a Phoenix business incubator dedicated to supporting technology-related startup and early-stage companies in the mission of quality JOB CREATION. CEI provides VALIDATION and COMMERCIALIZATION assistance for companies in the industries of: Medical Devices; Biosciences/Biotechnologies; Clean and Renewable Energies; Emerging Technologies and Software Development. In addition, CEI provides onsite rapid prototyping / 3D printing through PADT StartUpLabs, competitive intelligence services, business development and commercialization guidance with a seasoned Entrepreneur-in-Residence, office and wet lab space, and additional access to specialty biotechnology equipment. CEI does not take any equity in its client companies but does facilitate entrepreneur-investor relations and coaches its clients through investment principles, valuation, pitch, and more. Website: http://www.ceigateway.com
Investing in world-class bioscience research and training on behalf of the UK public. Funded by government, we fund research and postgraduate training at universities and research institutes in the UK through research grants.
Advanced crop technology for biofuel production ,Advanced crop technology focusing on energy feedstock. High quality biofuel production.
Tempo Bioscience (Tempo) is a technology development company. Our proprietary technologies and products serve as tools for pre-clinical drug discovery, cellular toxicology screening, drug development, and non-animal-based testing for the biotechnology, pharmaceutical, and chemical industries. Our main focus is on developing and manufacturing biosensors which can be incorporated into a variety of human cell types for pre-clinical discovery and drug development. Our biosensors are designed to work with immortalized human cell lines, human primary cells, and human stem cell (iPSC-) derived cell types. We strongly believe that advanced human cellular biosensor technologies from Tempo complement animal model studies, thereby strengthening scientific discoveries and drug development. For more info on our products, visit .
Generator of energy on site for use on demand. Produces gas for cooking, heating and/or electricity and thermal power for heating and hot water for kitchen and bathroom.
Modular product from a normal house to a factory, shopping center, town, etc.
Groken Bioscience provides you with a health monitoring tool to explore your "Other Genome", the genome of trillions of microorganism that share your body space. This "newly discovered organ" is found to have potentially overwhelming impact on human health, from obesity, heart health, respiratotary problems to behaviours.
Unlike our genome, you are able to change your microbiome. With this amazing potential, it is important to understand your microbiome. Using cutting edge genome sequencing and bioinformatics analysis, you can know what is your microbiome, how is it related to others and its changes overtime, we provide you actionable suggestions to change your microbiome hense improving your health.
We are the first in Asia and China, using big data on microbiome, to provide a tool for individuals to discover their microbiome. We aim at building an Asian specific microbiome database and an interactive interface to let individuals monitor and control this important health factor.
Caribou's technologies mark a revolutionary development that allows scientists to engineer nearly any part of any genome with extreme flexibility. Forbes Magazine has called Cas9 the protein that "could change biotech forever" and the New York Times has noted that "the pace of new discoveries and applications is dizzying." Our tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology.
Sonify is developing a medical device based on low-intensity ultrasound as an early-stage adjuvant treatment for melanoma and other skin cancers. With data in hand from our proof-of-concept experiments, we're looking to complete our currently open partially filled funding round. Next steps include beginning animal trials.
Armune has completed development and validated Apifiny™, a new prostate cancer diagnostic assay. The company has a clear path to revenue by offering Apifiny as a Laboratory Developed Test (LDT) in accordance with the Clinical Laboratory Improvement Amendments (CLIA) guidelines. CLIA compliance is monitored by the Centers for Medicare & Medicaid Services (CMS) and applies to all laboratory testing (except research) performed on humans in the U.S. Plans are in place to develop a prognostic that can differentiate between indolent and aggressive prostate cancer.
The technology can potentially be used as a diagnostic and prognostic for lung cancer and breast cancer.
Sothic develop wetware & bioreactor platform technologies for production of high-value biomolecules of use to the pharmaceutical industry and biomedical research areas.
LimuleX is a biosynthetic LAL (Limulus Amoebocyte Lysate), which replaces the current live animal derived source. It also reduces the burden of blood harvesting on the already threatened Atlantic Horseshoe Crab population.
KP Biosciences is a broad-spectrum antiviral development company with indications in influenza, herpesvirus, and orthopoxvirus. We have two antiviral agents that are called AK-11 and F4-4 with lead indications in influenza and acyclovir-resistant genital herpes, respectively.
Superlative BioSciencess Corp, is developing high-throughput in vitro assays using human cells in culture under conditions that mimic closely the human tissue microenvironment.
(1) The first system involves screening with human multipotent stem cells (umbilical cord blood or placenta derived mesenchymal stem cells) and is useful in determining the developmental toxicity of environmental chemicals.
(2) We are also developing human in vitro 3D multicellular systems that mimic various human tumor microenvironments.
(3) Our third project is the "Assembly of Multiple Organ Types and Configurations from Multipotent Mesenchymal Stem Cells Using 3D Printers".
We are seeking funding to establish and run cell culture screening systems that would be offered as a service-for-a-fee to companies within the chemical, fuels, and pharmaceutical industries.
Taxon develops biological based solutions through advancements in bioinformatics, genomics/sequencing, and biology culturing to meet the worlds growing energy demands. Taxon has products and applications in Heavy Oil upgrading, Coal to Methane conversion, and Enhanced Oil Recovery.
Spartan is bringing complete sample-to-result DNA testing systems to medicine. Spartan’s technology fully integrates DNA collection, extraction and analysis, with an intuitive interface that is easy to operate. For the first time, healthcare providers and their patients can get DNA results on demand.
Biosimulation: Use computers to better understand the mechanisms of life.
- Web-based simulation interfaces: Make your complex simulations easy to use.
- Simulation data management: Organize the results of your simulations.
- Custom hardware support: Make use of your hardware infrastructure to execute simulations.
Big Data: Structure the information of life.
- Clinical, pre-clinical and research data management: Organize your data from clinical, pre-clinical, or research studies.
- Experimental data, protocol and workflow management: Use the latest tools to tie data to scientific workflows and digitized protocols.
- Semantic data management: Use semantic technologies to enable higher order interpretation and analysis of your data.
Visualization and data exploration: Gain insight through beautiful interfaces.
- Rich web-based visualization dashboards: Use interactive visualizations of your data over the web.
- Visualizing scientific data: Get the right perspective on your data.
The Catalyst is KU's new student business accelerator. We provide resource access critical to startup launch success. Located at the Bioscience and Technology Business Center (BTBC) in West Campus, The Catalyst is managed by the KU Center for Entrepreneurship. Startups that are accepted into the program gain access to the following resources:
Flexible space in a high-tech, innovative environment at the BTBC
Access to seasoned entrepreneurs and domain experts to guide and coach teams
Teams will be immersed in the Lean LaunchPad approach, utilized at leading edge institutions
Dedicated student teams from Jayhawk Consulting will assist with secondary and primary research projects
Pro bono and reduced fee legal assistance is available for company structuring, IP, contracts and general business counseling
Access to Capital
Connecting teams to funding via grant opportunities, angels and business plan competitions
We are the physical hub for the growing and diverse group of start-ups in Southwestern CT. We create an environment where entrepreneurs can tap into deep Expertise, enthusiastic Talent, proven Service Providers and angel and VC capital.
Read about us in the NY Times - http://nyti.ms/zp7QPW
Come check us out stamfordicenter.com
Some of our companies: Color p.i., Arsanis Biosciences, Muddler, SynerScope, It's Relevant, and Mark My Media
Epiphany Biosciences is a biotechnology company focused on developing new therapeutics and diagnostic technologies that treat or prevent the spread of diseases of viral origin.
Thank you for creating the collection.
You can add startups from the list below